- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 103.82M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $40.91M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $82.65M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $177.68M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $181.73M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $423.01M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $453.37M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $200.84M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $237.93M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $927.1M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $954.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 104.54M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $6.34M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $6.46M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $21.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $472.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $478.78M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.07 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.07 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $8.02M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.69M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $32.19M |